Watch CBS News

Food and Drug Administration

cbsn-fusion-moderna-says-covid-vaccine-effective-in-kids-aged-6-to-11-thumbnail-823010-640x360.jpg

Moderna says COVID vaccine is effective in kids

Millions of children under the age of 12 could be eligible for a COVID-19 vaccine in just a matter of weeks. Moderna says a low dosage of its coronavirus vaccine is safe and appears effective in kids age 6 to 11. Meanwhile, an FDA committee will meet Tuesday to discuss whether to approve Pfizer's vaccine for children. CBS News correspondent Meg Oliver has the latest. Then, Dr. Shikha Jain, assistant professor of medicine at the University of Illinois Chicago, joins CBSN's Elaine Quijano to discuss.

cbsn-fusion-fda-authorizes-jj-and-moderna-booster-shots-ahead-of-cdc-panel-meeting-thumbnail-819618-640x360.jpg

FDA authorizes J&J and Moderna booster shots

The FDA has authorized COVID-19 booster shots for some recipients of the Johnson and Johnson and Moderna vaccines. But as Nikki Battiste reports, the agency says eligible Americans can get any brand of booster, regardless of the shot they initially got. Then, Dr. Elizabeth Clayborne, an emergency physician and adjunct professor of emergency medicine at the University of Maryland School of Medicine, joins CBSN's Lana Zak with her analysis.

cbsn-fusion-fda-advisory-panel-unanimously-votes-to-recommend-johnson-and-johnson-booster-shot-thumbnail-816453-640x360.jpg

FDA panel recommends J&J booster shot

The FDA advisory panel unanimously voted to recommend the Johnson & Johnson booster shot on Friday. It comes a day after the same panel made the recommendation for a third Moderna shot. President Biden says full FDA and CDC approval for both boosters could come as early as next week. CBS News reporter Max Bayer and John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, join CBSN's Tanya Rivero to discuss the FDA panel's vote.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.